NCT01278485 Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402) Status COMPLETED Phase N/A
NCT01275235 Exposure to Type II Diabetes for Two Siblings With the Same Parents Status TERMINATED Phase N/A
NCT01269996 JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT01263509 Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01263496 Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2
NCT01263483 Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Status COMPLETED Phase PHASE2/PHASE3
NCT01257451 Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT01257087 Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery Status COMPLETED Phase NA
NCT01254552 Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis Status COMPLETED Phase PHASE4
NCT01250639 Type 2 Diabetes Mellitus Collaborative Genetic Study on Non-aboriginal Taiwanese Status UNKNOWN Phase N/A
NCT01242228 A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01242215 A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01242202 A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients Status COMPLETED Phase PHASE3
NCT01241253 Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT01240759 Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy Status COMPLETED Phase PHASE2